(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione

Catalog No. :
ACVGQC153
CAS No. :
1454257-31-8
Molecular Formula :
C23H27F6N3O2
Molecular Weight :
491.48

IUPAC Name:(S)-3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione

(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione
IUPAC Name(S)-3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-((3,3-dimethyl-1-(piperidin-1-yl)butan-2-yl)amino)cyclobut-3-ene-1,2-dione
Molecular FormulaC23H27F6N3O2
Molecular Weight491.48
SMILESO=C1C(C(NC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)=C1N[C@@H](C(C)(C)C)CN3CCCCC3)=O
InChI KeyCPZAIFUPGVZMII-MRXNPFEDSA-N
Synonym3-Cyclobutene-1,2-dione, 3-[[3,5-bis(trifluoromethyl)phenyl]amino]-4-[[(1S)-2,2-dimethyl-1-(1-piperidinylmethyl)propyl]amino]-
CAS No.1454257-31-8

Synthetic Route by SureRoute

1. ACVGQC153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQUXN258 route compound structure diagram
    ACQUXN258328-70-1 In Stock
  4. Then
  5. ACVGQC153 route product structure diagram
    ACVGQC1531454257-31-8
Inquiry

2. ACVGQC153 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNRTS705 route compound structure diagram
    ACNRTS705328-74-5 In Stock
  4. Then
  5. ACVGQC153 route product structure diagram
    ACVGQC1531454257-31-8
Inquiry

Comments (0)